Intrinsic Value of S&P & Nasdaq Contact Us

Ocuphire Pharma, Inc. OCUP NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
51/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — OCUP

Ocuphire Pharma, Inc. (OCUP) has a market capitalization of $31.74M and trades at $1.17. The 52-week range is 1.0715-3.3994.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.5, Earnings Per Share (EPS) of $-0.80.

The stock has a beta of 0.31, operates in the Healthcare sector.

Trading Data
Current Price$1.17
52-Week Range1.0715-3.3994
Volume675.97K
Avg Volume (30D)139.15K
Market Cap$31.74M
Beta (1Y)0.31
Company
IPO Date2005-11-10
Employees14
CEOGeorge Magrath
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS67577R1023
CUSIP67577R102
Income (Latest Year)
EBITDA$-38.6M
Operating Income$-38.6M
Net Income$-49.59M
EPS$-0.80
EPS Diluted$-0.80
Shares Outstanding$622.22M
Balance Sheet (Latest Year)
Total Assets$50.24M
Current Assets$50.04M
Cash & ST Investments$45.09M
Total Liabilities$34.9M
Net Debt$-45.09M
Total Equity$15.35M
Valuation Ratios
P/E Ratio-1.5
P/B Ratio2.07
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message